Mani, Inc. (7730) AI Stock Analysis

• Market Cap: ¥121.62B
• Dividend Yield: 2.59%
• Average Volume (3M): 303.04K
• Price to Earnings (P/E): 20.1
• Beta (1Y): 0.86
• Revenue Growth: 11.54%
• EPS Growth: -8.30%
• Country: JP
• Employees: 4,154
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 13.62
• Shares Outstanding: 107,003,280
• 10 Day Avg. Volume: 345,790
• 30 Day Avg. Volume: 303,040
• PEG Ratio: 0.65
• Price to Book (P/B): 6.92
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 61.43
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,100.00
• Price Target Upside: -9.39% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 76 Outperform
• Price Target: ¥1,357.00 ▲(11.78%Upside)

Mani, Inc. has a strong financial foundation with increasing revenue and robust profit margins, contributing significantly to the overall score. Technical analysis provides a mixed outlook, with short-term resilience but potential long-term challenges. Valuation is fair, supported by a reasonable P/E ratio and an attractive dividend yield. The absence of recent earnings call insights or notable corporate events leaves these areas neutral.

Mani, Inc. Business Overview & Revenue Model

Company Description

Mani, Inc. (7730) is a Japanese company primarily engaged in the manufacture and sale of medical instruments, dental instruments, and surgical instruments. The company operates through various segments, including dental products, surgical products, and ophthalmic products. It provides a wide array of products such as dental reamers, root canal files, and other dental products, surgical sutures, needles, and other surgical instruments, as well as ophthalmic instruments and related products.

How the Company Makes Money

Mani, Inc. generates revenue through the sale of its medical, dental, and surgical instruments worldwide. The company earns a substantial portion of its income from the dental segment, which involves selling specialized tools and instruments to dental professionals and clinics. Additionally, its surgical products division contributes significantly to its earnings by providing hospitals and medical institutions with high-quality surgical sutures and needles. Mani, Inc. also benefits from its global distribution network and partnerships with healthcare providers, ensuring a consistent demand for its products across various international markets.

Mani, Inc. Financial Statement Overview

Summary

Mani, Inc. shows robust financial performance with strong revenue growth and profitability margins. The balance sheet is stable with minimal leverage, although free cash flow volatility due to high capital expenditures is a concern. Overall, the company is financially sound with a solid foundation for future growth.

Income Statement

Mani, Inc. demonstrates strong financial performance with a consistent increase in revenue from 2020 to 2024. The gross profit margin has remained robust, reflecting efficient cost management. Net profit margin has improved, indicating enhanced profitability. Notably, the EBIT and EBITDA margins have shown positive trends, underscoring operational efficiency.

Balance Sheet

The balance sheet of Mani, Inc. reflects financial stability with a low debt-to-equity ratio, indicating conservative leverage. The return on equity is strong, showcasing effective use of shareholders' equity to generate profits. A high equity ratio further illustrates the company's solid financial foundation.

Cash Flow

Mani, Inc. displays a mixed cash flow performance. While operating cash flow is healthy, free cash flow has shown volatility due to significant capital expenditures in recent years. The free cash flow to net income ratio is low, suggesting potential constraints in cash availability for strategic investments.

Breakdown	TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	29.05B	28.51B	24.49B	20.42B	17.19B	15.20B
Gross Profit	18.45B	17.90B	15.42B	12.57B	11.01B	9.88B
EBITDA	10.47B	10.70B	9.94B	9.17B	7.55B	6.26B
Net Income	6.31B	6.29B	5.95B	5.29B	4.29B	3.33B
Balance Sheet
Total Assets	57.33B	57.18B	54.98B	50.11B	42.69B	39.29B
Cash, Cash Equivalents and Short-Term Investments	21.53B	21.66B	25.43B	22.73B	18.89B	17.18B
Total Debt	74.00M	83.00M	58.00M	117.00M	128.00M	62.48M
Total Liabilities	4.99B	4.85B	5.15B	4.70B	3.49B	2.72B
Stockholders Equity	52.34B	52.33B	49.83B	45.41B	39.20B	36.57B
Cash Flow
Free Cash Flow	0.00	129.00M	4.31B	4.62B	2.52B	248.97M
Operating Cash Flow	0.00	7.81B	8.03B	6.56B	6.38B	1.94B
Investing Cash Flow	0.00	-6.64B	-4.02B	-2.17B	-3.44B	-38.33M
Financing Cash Flow	0.00	-3.70B	-3.25B	-2.44B	-2.23B	-2.13B

Mani, Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1214.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Neutral. The current price of 1214 is above the 20-day moving average (MA) of 1201.70, above the 50-day MA of 1192.49, and below the 200-day MA of 1483.29, indicating a neutral trend. The MACD of 5.79 indicates Negative momentum. The RSI at 53.18 is Neutral, neither overbought nor oversold. The STOCH value of 65.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7730.

Mani, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	80 Outperform	¥136.87B	15.92	6.55%	3.87%	2.42%	-13.12%
7730	76 Outperform	¥121.62B	20.15		2.59%	11.54%	-8.30%
7747	74 Outperform	$611.02B	58.02	7.09%	1.08%	17.38%	-30.54%
7716	71 Outperform	¥161.81B	28.29	4.78%	2.75%	20.53%	-75.16%
Sector *	64 Neutral	¥343.76B	10.59	-2.88%	2.57%	11.81%	-7.17%
7979	61 Neutral	¥70.51B	16.26		3.14%	15.55%	42.14%
7780	61 Neutral	€86.10B	15.29	6.62%	2.47%	4.56%	24.10%